nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Imiquimod—skin cancer	0.187	0.233	CbGbCtD
Dihydrocodeine—CYP3A4—Temozolomide—skin cancer	0.187	0.233	CbGbCtD
Dihydrocodeine—CYP2D6—Vemurafenib—skin cancer	0.161	0.201	CbGbCtD
Dihydrocodeine—CYP3A4—Vismodegib—skin cancer	0.129	0.162	CbGbCtD
Dihydrocodeine—CYP3A4—Vemurafenib—skin cancer	0.102	0.128	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—skin cancer	0.0351	0.0438	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Vismodegib—skin cancer	0.00886	0.0445	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Imiquimod—skin cancer	0.00467	0.0235	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.0031	0.0156	CcSEcCtD
Dihydrocodeine—Urinary retention—Imiquimod—skin cancer	0.00305	0.0153	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Vismodegib—skin cancer	0.00293	0.0147	CcSEcCtD
Dihydrocodeine—Skin disorder—Vismodegib—skin cancer	0.0029	0.0146	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Temozolomide—skin cancer	0.0028	0.0141	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00258	0.013	CcSEcCtD
Dihydrocodeine—Constipation—Vismodegib—skin cancer	0.00256	0.0129	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Vismodegib—skin cancer	0.00244	0.0123	CcSEcCtD
Dihydrocodeine—Abdominal pain—Vismodegib—skin cancer	0.00236	0.0119	CcSEcCtD
Dihydrocodeine—Angiopathy—Vemurafenib—skin cancer	0.00236	0.0119	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Vemurafenib—skin cancer	0.00234	0.0118	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Imiquimod—skin cancer	0.00234	0.0117	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Imiquimod—skin cancer	0.00219	0.011	CcSEcCtD
Dihydrocodeine—Urethral disorder—Imiquimod—skin cancer	0.00217	0.0109	CcSEcCtD
Dihydrocodeine—Pruritus—Vismodegib—skin cancer	0.00212	0.0106	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vismodegib—skin cancer	0.00205	0.0103	CcSEcCtD
Dihydrocodeine—Angiopathy—Imiquimod—skin cancer	0.00201	0.0101	CcSEcCtD
Dihydrocodeine—Immune system disorder—Imiquimod—skin cancer	0.002	0.0101	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Imiquimod—skin cancer	0.002	0.01	CcSEcCtD
Dihydrocodeine—Mental disorder—Imiquimod—skin cancer	0.00194	0.00977	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00191	0.00962	CcSEcCtD
Dihydrocodeine—Vomiting—Vismodegib—skin cancer	0.0019	0.00956	CcSEcCtD
Dihydrocodeine—Affect lability—Temozolomide—skin cancer	0.00189	0.00951	CcSEcCtD
Dihydrocodeine—Rash—Vismodegib—skin cancer	0.00189	0.00948	CcSEcCtD
Dihydrocodeine—Dermatitis—Vismodegib—skin cancer	0.00188	0.00947	CcSEcCtD
Dihydrocodeine—Mood swings—Temozolomide—skin cancer	0.00182	0.00915	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Vemurafenib—skin cancer	0.00181	0.00911	CcSEcCtD
Dihydrocodeine—Skin disorder—Vemurafenib—skin cancer	0.00179	0.00902	CcSEcCtD
Dihydrocodeine—Nausea—Vismodegib—skin cancer	0.00178	0.00893	CcSEcCtD
Dihydrocodeine—Angioedema—Imiquimod—skin cancer	0.00176	0.00887	CcSEcCtD
Dihydrocodeine—Hypotension—Vemurafenib—skin cancer	0.00173	0.00868	CcSEcCtD
Dihydrocodeine—Convulsion—Imiquimod—skin cancer	0.00167	0.00841	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00163	0.00821	CcSEcCtD
Dihydrocodeine—Dry mouth—Imiquimod—skin cancer	0.00161	0.00808	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00159	0.00802	CcSEcCtD
Dihydrocodeine—Constipation—Vemurafenib—skin cancer	0.00158	0.00794	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Imiquimod—skin cancer	0.00154	0.00777	CcSEcCtD
Dihydrocodeine—Skin disorder—Imiquimod—skin cancer	0.00153	0.00769	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Imiquimod—skin cancer	0.00152	0.00766	CcSEcCtD
Dihydrocodeine—Paraesthesia—Imiquimod—skin cancer	0.00141	0.00711	CcSEcCtD
Dihydrocodeine—Dyspnoea—Imiquimod—skin cancer	0.0014	0.00706	CcSEcCtD
Dihydrocodeine—Somnolence—Imiquimod—skin cancer	0.0014	0.00704	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Temozolomide—skin cancer	0.0014	0.00704	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00136	0.00684	CcSEcCtD
Dihydrocodeine—Hallucination—Temozolomide—skin cancer	0.00132	0.00665	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Temozolomide—skin cancer	0.00131	0.0066	CcSEcCtD
Dihydrocodeine—Pruritus—Vemurafenib—skin cancer	0.00131	0.00657	CcSEcCtD
Dihydrocodeine—Urethral disorder—Temozolomide—skin cancer	0.0013	0.00655	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Imiquimod—skin cancer	0.0013	0.00653	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Imiquimod—skin cancer	0.00129	0.00648	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vemurafenib—skin cancer	0.00126	0.00635	CcSEcCtD
Dihydrocodeine—Urticaria—Imiquimod—skin cancer	0.00125	0.00629	CcSEcCtD
Dihydrocodeine—Abdominal pain—Imiquimod—skin cancer	0.00125	0.00626	CcSEcCtD
Dihydrocodeine—Dizziness—Vemurafenib—skin cancer	0.00122	0.00614	CcSEcCtD
Dihydrocodeine—Angiopathy—Temozolomide—skin cancer	0.00121	0.00606	CcSEcCtD
Dihydrocodeine—Immune system disorder—Temozolomide—skin cancer	0.0012	0.00603	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Temozolomide—skin cancer	0.0012	0.00602	CcSEcCtD
Dihydrocodeine—Vomiting—Vemurafenib—skin cancer	0.00117	0.0059	CcSEcCtD
Dihydrocodeine—Rash—Vemurafenib—skin cancer	0.00116	0.00586	CcSEcCtD
Dihydrocodeine—Mental disorder—Temozolomide—skin cancer	0.00116	0.00585	CcSEcCtD
Dihydrocodeine—Dermatitis—Vemurafenib—skin cancer	0.00116	0.00585	CcSEcCtD
Dihydrocodeine—Headache—Vemurafenib—skin cancer	0.00116	0.00582	CcSEcCtD
Dihydrocodeine—Confusional state—Bleomycin—skin cancer	0.00113	0.00567	CcSEcCtD
Dihydrocodeine—Pruritus—Imiquimod—skin cancer	0.00111	0.0056	CcSEcCtD
Dihydrocodeine—Nausea—Vemurafenib—skin cancer	0.0011	0.00552	CcSEcCtD
Dihydrocodeine—Diarrhoea—Imiquimod—skin cancer	0.00108	0.00542	CcSEcCtD
Dihydrocodeine—Angioedema—Temozolomide—skin cancer	0.00106	0.00531	CcSEcCtD
Dihydrocodeine—Hypotension—Bleomycin—skin cancer	0.00105	0.00526	CcSEcCtD
Dihydrocodeine—Dizziness—Imiquimod—skin cancer	0.00104	0.00524	CcSEcCtD
Dihydrocodeine—Vertigo—Temozolomide—skin cancer	0.00104	0.00523	CcSEcCtD
Dihydrocodeine—Paraesthesia—Bleomycin—skin cancer	0.001	0.00505	CcSEcCtD
Dihydrocodeine—Convulsion—Temozolomide—skin cancer	0.001	0.00504	CcSEcCtD
Dihydrocodeine—Vomiting—Imiquimod—skin cancer	0.001	0.00504	CcSEcCtD
Dihydrocodeine—Dyspnoea—Bleomycin—skin cancer	0.000998	0.00502	CcSEcCtD
Dihydrocodeine—Rash—Imiquimod—skin cancer	0.000993	0.00499	CcSEcCtD
Dihydrocodeine—Dermatitis—Imiquimod—skin cancer	0.000992	0.00499	CcSEcCtD
Dihydrocodeine—Headache—Imiquimod—skin cancer	0.000987	0.00496	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000978	0.00492	CcSEcCtD
Dihydrocodeine—Dry mouth—Temozolomide—skin cancer	0.000963	0.00484	CcSEcCtD
Dihydrocodeine—Confusional state—Temozolomide—skin cancer	0.000952	0.00479	CcSEcCtD
Dihydrocodeine—Nausea—Imiquimod—skin cancer	0.000936	0.0047	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Docetaxel—skin cancer	0.000931	0.00468	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Temozolomide—skin cancer	0.000926	0.00465	CcSEcCtD
Dihydrocodeine—Convulsion—Fluorouracil—skin cancer	0.000923	0.00464	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Bleomycin—skin cancer	0.000922	0.00464	CcSEcCtD
Dihydrocodeine—Skin disorder—Temozolomide—skin cancer	0.000917	0.00461	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Temozolomide—skin cancer	0.000913	0.00459	CcSEcCtD
Dihydrocodeine—Urticaria—Bleomycin—skin cancer	0.000889	0.00447	CcSEcCtD
Dihydrocodeine—Confusional state—Fluorouracil—skin cancer	0.000877	0.00441	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Docetaxel—skin cancer	0.000873	0.00439	CcSEcCtD
Dihydrocodeine—Urethral disorder—Docetaxel—skin cancer	0.000866	0.00436	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dactinomycin—skin cancer	0.00086	0.00432	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000854	0.00429	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Fluorouracil—skin cancer	0.000853	0.00429	CcSEcCtD
Dihydrocodeine—Paraesthesia—Temozolomide—skin cancer	0.000848	0.00426	CcSEcCtD
Dihydrocodeine—Dyspnoea—Temozolomide—skin cancer	0.000842	0.00423	CcSEcCtD
Dihydrocodeine—Somnolence—Temozolomide—skin cancer	0.000839	0.00422	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dactinomycin—skin cancer	0.000825	0.00415	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000815	0.0041	CcSEcCtD
Dihydrocodeine—Hypotension—Fluorouracil—skin cancer	0.000813	0.00409	CcSEcCtD
Dihydrocodeine—Constipation—Temozolomide—skin cancer	0.000807	0.00406	CcSEcCtD
Dihydrocodeine—Angiopathy—Docetaxel—skin cancer	0.000802	0.00403	CcSEcCtD
Dihydrocodeine—Immune system disorder—Docetaxel—skin cancer	0.000798	0.00401	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Docetaxel—skin cancer	0.000796	0.004	CcSEcCtD
Dihydrocodeine—Pruritus—Bleomycin—skin cancer	0.000792	0.00398	CcSEcCtD
Dihydrocodeine—Paraesthesia—Fluorouracil—skin cancer	0.000781	0.00393	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Temozolomide—skin cancer	0.000778	0.00391	CcSEcCtD
Dihydrocodeine—Dyspnoea—Fluorouracil—skin cancer	0.000775	0.0039	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—skin cancer	0.000774	0.00389	CcSEcCtD
Dihydrocodeine—Somnolence—Fluorouracil—skin cancer	0.000773	0.00389	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Temozolomide—skin cancer	0.000772	0.00388	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000751	0.00378	CcSEcCtD
Dihydrocodeine—Urticaria—Temozolomide—skin cancer	0.00075	0.00377	CcSEcCtD
Dihydrocodeine—Abdominal pain—Temozolomide—skin cancer	0.000746	0.00375	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Fluorouracil—skin cancer	0.000717	0.0036	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dactinomycin—skin cancer	0.000714	0.00359	CcSEcCtD
Dihydrocodeine—Vomiting—Bleomycin—skin cancer	0.000712	0.00358	CcSEcCtD
Dihydrocodeine—Rash—Bleomycin—skin cancer	0.000706	0.00355	CcSEcCtD
Dihydrocodeine—Dermatitis—Bleomycin—skin cancer	0.000705	0.00354	CcSEcCtD
Dihydrocodeine—Urticaria—Fluorouracil—skin cancer	0.000691	0.00347	CcSEcCtD
Dihydrocodeine—Pruritus—Temozolomide—skin cancer	0.000668	0.00336	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—skin cancer	0.000666	0.00335	CcSEcCtD
Dihydrocodeine—Nausea—Bleomycin—skin cancer	0.000665	0.00334	CcSEcCtD
Dihydrocodeine—Vomiting—Dactinomycin—skin cancer	0.000664	0.00334	CcSEcCtD
Dihydrocodeine—Rash—Dactinomycin—skin cancer	0.000658	0.00331	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00065	0.00327	CcSEcCtD
Dihydrocodeine—Diarrhoea—Temozolomide—skin cancer	0.000646	0.00325	CcSEcCtD
Dihydrocodeine—Dry mouth—Docetaxel—skin cancer	0.00064	0.00322	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—skin cancer	0.000633	0.00318	CcSEcCtD
Dihydrocodeine—Dizziness—Temozolomide—skin cancer	0.000624	0.00314	CcSEcCtD
Dihydrocodeine—Nausea—Dactinomycin—skin cancer	0.00062	0.00312	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—skin cancer	0.000616	0.0031	CcSEcCtD
Dihydrocodeine—Pruritus—Fluorouracil—skin cancer	0.000615	0.00309	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—skin cancer	0.00061	0.00307	CcSEcCtD
Dihydrocodeine—Vomiting—Temozolomide—skin cancer	0.0006	0.00302	CcSEcCtD
Dihydrocodeine—Rash—Temozolomide—skin cancer	0.000595	0.00299	CcSEcCtD
Dihydrocodeine—Diarrhoea—Fluorouracil—skin cancer	0.000595	0.00299	CcSEcCtD
Dihydrocodeine—Dermatitis—Temozolomide—skin cancer	0.000595	0.00299	CcSEcCtD
Dihydrocodeine—Headache—Temozolomide—skin cancer	0.000591	0.00297	CcSEcCtD
Dihydrocodeine—Hypotension—Docetaxel—skin cancer	0.000587	0.00295	CcSEcCtD
Dihydrocodeine—Dizziness—Fluorouracil—skin cancer	0.000575	0.00289	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—skin cancer	0.000564	0.00283	CcSEcCtD
Dihydrocodeine—Nausea—Temozolomide—skin cancer	0.000561	0.00282	CcSEcCtD
Dihydrocodeine—Dyspnoea—Docetaxel—skin cancer	0.00056	0.00281	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—skin cancer	0.000558	0.00281	CcSEcCtD
Dihydrocodeine—Vomiting—Fluorouracil—skin cancer	0.000553	0.00278	CcSEcCtD
Dihydrocodeine—Rash—Fluorouracil—skin cancer	0.000548	0.00276	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluorouracil—skin cancer	0.000548	0.00275	CcSEcCtD
Dihydrocodeine—Headache—Fluorouracil—skin cancer	0.000545	0.00274	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000542	0.00273	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—skin cancer	0.000537	0.0027	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—skin cancer	0.000517	0.0026	CcSEcCtD
Dihydrocodeine—Nausea—Fluorouracil—skin cancer	0.000517	0.0026	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—skin cancer	0.000513	0.00258	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—skin cancer	0.000496	0.0025	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—skin cancer	0.000444	0.00223	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—skin cancer	0.00043	0.00216	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—skin cancer	0.000415	0.00209	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—skin cancer	0.000399	0.00201	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—skin cancer	0.000396	0.00199	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—skin cancer	0.000395	0.00199	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—skin cancer	0.000393	0.00198	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—skin cancer	0.000373	0.00187	CcSEcCtD
